Reported Jul 20, 2016 · Terminated

B-COMPLEX WITHOUT B12 (PF) IN NACL 0.9%, B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG/ML, In a) 2ML Vials and b) 5ML…

Medaus, Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Medaus, Inc. · 6801 Cahaba Valley Rd Ste 116 · Birmingham, AL · 35242-9609

Is this the product you have?

    • B-COMPLEX WITHOUT B12 (PF) IN NACL 0.9%
    • B1-100MG
    • B2-5-PO4-2MG
    • B3-50MG
    • B5-2MG
    • B6-2MG/ML
    • In a) 2ML Vials and b) 5ML Vials
    • MEDAUS PHARMACY
Lot codes and dates
  • a) Lot #: 151130-66
  • BUD
    • 05/28/16
    • Lot #: 160222-51
  • BUD08/20/16. b) Lot #: 151130-60
  • BUD
    • 05/28/16
    • Lot #: 160222-51
  • BUD08/20/16
Amount recalled
4000 mL in Vials

This recall covers 88 products

The agency filed one notice per product. You are reading one of them; the other 87 are below.

75 more are in the archive.

Where it was sold

  • Nationwide

Why it was recalled

Lack of Assurance of Sterility

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Medaus, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Jun 16, 2017 · Data as of Sep 19, 5:04 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.